The Priority Review

Tag

AT-III concentrate

1 story

  1. Clinical trials

    Instituto Grifols posts results of Phase II/III trial of plasma-derived AT-III concentrate

    The study enrolled 3 participants with Antithrombin III Deficiency and began on April 15, 2008. It was terminated after primary completion in December 2011.